Skip to content

Alexandria Study I - Demonstration of Safety and Efficacy of the EYEPCR RING with Senile (Age Related) cataract

Alexandria Study I - Demonstration of Safety and Efficacy of the EYEPCR RING with Senile (Age Related) cataract

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202106741373163
Enrollment
120
Registered
2021-06-07
Start date
2019-12-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Sponsors

EYEPCR B.V.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults 2. Cataract patients classified using LOCS III Grating, Grade 1 (Nuclear), Grade 2 (Cortical) or Grade 3 (Posterior) 3. Suitable to receive a standard monofocal IOL having a power range between 15 and 25 diopters 4. 4 Clear intraocular media other than cataract 5. No previous intraocular or corneal surgery 6. No traumatic cataract 7. Stability of keratometry or biometry measurements. No indication of corneal ecstatic conditions or other corneal dystrophies 8. No irregular astigmatism 9. No pregnancy potential or lactation 10. Not concurrent participation in another drug or device investigation 11. Availability for postoperative follow up 12. Ability to sign the inform consent form

Exclusion criteria

Exclusion criteria: 1. Dense cataract 2. Cataract patients which also have additional anterior segment ophthalmic pathology (e.g. glaucoma, pseudoexfoliation syndrome). 3. Previous corneal surgeries (LASIK, PRK, CCL, etc) 4. Monocular patient 5. Patients who are not available for post operative follow up 6. 6. Patients who cannot consent to their enrolment the study.

Design outcomes

Primary

MeasureTime frame
Post operative Best Spectacle Corrected Visual Acuity (BSCVA), Post operative Uncorrected Visual Acuity (UCVA), Standard deviation of the refractive surprise (Intended - Achieved refraction), Intraocular lens centration and tilt.

Secondary

MeasureTime frame
PCO incidence

Countries

Egypt

Contacts

Public ContactIbtesam Yakoot

Assistant in Ophthalmological Clinic

tantysam@yahoo.com00201001536564

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026